BOSTON, Dec 4 (Reuters) - Two companies now owned by Medtronic Plc will pay $30.9 million to resolve claims that they marketed a medical device for unapproved purposes and paid kickbacks to hospitals in exchange for them using a second device.
The U.S. Justice Department announced the settlement on Tuesday. As part of the deal, ev3 Inc, a medical device manufacturer now owned by Medtronic, has agreed to plead guilty to a charge related to a neurovascular medical device. (Reporting by Nate Raymond in Boston Editing by Marguerita Choy)
